OTCMKTS:VASO

Vaso News Headlines

$0.07
-0.01 (-13.20 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.07
$0.07
50-Day Range
$0.07
$0.12
52-Week Range
$0.01
$0.18
Volume293,226 shs
Average Volume306,346 shs
Market Capitalization$12.18 million
P/E Ratio3.29
Dividend YieldN/A
Beta3.26

Headlines

Vaso (OTCMKTS VASO) News Headlines Today

SourceHeadline
Vaso (OTCMKTS:VASO) Share Price Passes Above Two Hundred Day Moving Average of $0.08Vaso (OTCMKTS:VASO) Share Price Passes Above Two Hundred Day Moving Average of $0.08
americanbankingnews.com - May 7 at 12:50 AM
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2020Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2020
finance.yahoo.com - May 4 at 8:49 PM
Short Interest in Vaso Co. (OTCMKTS:VASO) Rises By 166.2%Short Interest in Vaso Co. (OTCMKTS:VASO) Rises By 166.2%
americanbankingnews.com - April 29 at 5:10 AM
Vaso (OTCMKTS:VASO) Share Price Passes Above 200-Day Moving Average of $0.08Vaso (OTCMKTS:VASO) Share Price Passes Above 200-Day Moving Average of $0.08
americanbankingnews.com - April 28 at 2:16 AM
Vaso Corporation Expects to Report 2020 Financial Results by April 30, 2021Vaso Corporation Expects to Report 2020 Financial Results by April 30, 2021
finance.yahoo.com - April 15 at 7:00 PM
Non-invasive Blood Pressure Monitors Market Projected to Hit at a Strong CAGR Between Forecast Period 2020 - 2027 by ARCNon-invasive Blood Pressure Monitors Market Projected to Hit at a Strong CAGR Between Forecast Period 2020 - 2027 by ARC
marketwatch.com - March 23 at 4:20 AM
SemaThera Enters into a Research Collaboration and Exclusive License Agreement with RocheSemaThera Enters into a Research Collaboration and Exclusive License Agreement with Roche
finance.yahoo.com - March 22 at 1:17 PM
Imara Reports Full Year 2020 Financial Results and Business HighlightsImara Reports Full Year 2020 Financial Results and Business Highlights
finance.yahoo.com - March 5 at 7:24 AM
Treatment with Investigational LentiGlobin™ Gene Therapy for Sickle Cell Disease (bb1111) Results in Complete Elimination of SCD-Related Severe Vaso-Occlusive Events in Group ...Treatment with Investigational LentiGlobin™ Gene Therapy for Sickle Cell Disease (bb1111) Results in Complete Elimination of SCD-Related Severe Vaso-Occlusive Events in Group ...
businesswire.com - December 9 at 8:50 PM
Vaso Corporation Reports Financial Results for Third Quarter 2020Vaso Corporation Reports Financial Results for Third Quarter 2020
finance.yahoo.com - November 13 at 1:37 PM
Axcella Health Inc. (AXLA) CEO Bill Hinshaw on Q3 2020 Results - Earnings Call TranscriptAxcella Health Inc. (AXLA) CEO Bill Hinshaw on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 2:37 PM
Global Platelet Aggregation Devices Market Expanding to Cross USD 1,556.8 million by 2027Global Platelet Aggregation Devices Market Expanding to Cross USD 1,556.8 million by 2027
marketwatch.com - November 12 at 2:37 PM
GlycoMimetics Inc (GLYC) Q3 2020 Earnings Call TranscriptGlycoMimetics Inc (GLYC) Q3 2020 Earnings Call Transcript
nasdaq.com - November 6 at 10:30 PM
GlycoMimetics (GLYC) CEO Rachel King on Q3 2020 Results - Earnings Call TranscriptGlycoMimetics' (GLYC) CEO Rachel King on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 12:29 PM
Explained: Life of Keshubhai Patel, RSS karyakarta, Bharatiya Jana Sangh founder, Gujarat CMExplained: Life of Keshubhai Patel, RSS karyakarta, Bharatiya Jana Sangh founder, Gujarat CM
msn.com - October 29 at 1:56 PM
Gujarat: Kheda constable, two others held for ‘smuggling liquor’Gujarat: Kheda constable, two others held for ‘smuggling liquor’
msn.com - October 27 at 5:00 PM
Vertex: Recent Clinical Setback Underscores The Need To Expand The PipelineVertex: Recent Clinical Setback Underscores The Need To Expand The Pipeline
seekingalpha.com - October 24 at 11:07 PM
News for Vaso Corporation Registered ShsNews for Vaso Corporation Registered Shs
markets.businessinsider.com - October 22 at 6:15 PM
Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Demand and Supply Analysis 2020 to 2026Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Demand and Supply Analysis 2020 to 2026
marketwatch.com - September 2 at 3:10 AM
Vaso Corporation Announces Financial Results for Second Quarter 2020Vaso Corporation Announces Financial Results for Second Quarter 2020
finance.yahoo.com - August 14 at 12:24 PM
GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2020 Results - Earnings Call TranscriptGlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 1 at 12:38 AM
Novartis International AG: Novartis Adakveo® receives positive CHMP opinion for the prevention of recurrent vaso-occlusiveNovartis International AG: Novartis Adakveo® receives positive CHMP opinion for the prevention of recurrent vaso-occlusive
www.bloomberg.com - July 26 at 11:16 PM
Novartis Adakveo® receives positive CHMP opinion for the prevention of recurrent vaso-occlusive crises in patients with sickle cell diseaseNovartis Adakveo® receives positive CHMP opinion for the prevention of recurrent vaso-occlusive crises in patients with sickle cell disease
www.benzinga.com - July 24 at 9:49 AM
bluebird On The Go, And Other News: The Good, Bad And Ugly Of Biopharmabluebird On The Go, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - June 17 at 11:29 PM
Vaso Corporation Announces Financial Results for First Quarter 2020Vaso Corporation Announces Financial Results for First Quarter 2020
finance.yahoo.com - June 4 at 12:20 PM
Whats The Best Biotech Stock to Buy for Treating Sickle Cell Disease?What's The Best Biotech Stock to Buy for Treating Sickle Cell Disease?
www.fool.com - April 22 at 8:31 AM
ABPM Patient Monitors Market Still Has Room to Grow | Emerging Players Medtronic, Vaso, Welch AllynABPM Patient Monitors Market Still Has Room to Grow | Emerging Players Medtronic, Vaso, Welch Allyn
www.marketwatch.com - April 16 at 7:58 AM
FORMA Therapeutics Receives FDA Orphan Drug Designation for FT-4202 for the Treatment of Sickle Cell DiseaseFORMA Therapeutics Receives FDA Orphan Drug Designation for FT-4202 for the Treatment of Sickle Cell Disease
www.businesswire.com - April 15 at 9:53 AM
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year for 2019Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year for 2019
finance.yahoo.com - April 14 at 6:34 PM
Non-invasive Monitoring Devices Market Anticipated to Mask at a CAGR 5.6% by 2027|Omron Corporation, Vaso Corporation, Integrity ApplicationsNon-invasive Monitoring Devices Market Anticipated to Mask at a CAGR 5.6% by 2027|Omron Corporation, Vaso Corporation, Integrity Applications
www.marketwatch.com - April 7 at 6:02 PM
Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-OcclusivePfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive
www.bloomberg.com - March 31 at 12:13 AM
Vaso Corp.Vaso Corp.
www.marketwatch.com - March 27 at 12:28 AM
Global Digital Voice Recorders Market Analysis 2020 – Dynamics, Trends, Revenue, Regional Segmented, Outlook & Forecast Till 2026Global Digital Voice Recorders Market Analysis 2020 – Dynamics, Trends, Revenue, Regional Segmented, Outlook & Forecast Till 2026
www.benzinga.com - March 25 at 9:00 AM
What Happens When You Drink a Glass of Wine Every NightWhat Happens When You Drink a Glass of Wine Every Night
www.msn.com - March 17 at 8:06 AM
FORMA Therapeutics Announces FT-4202 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Sickle Cell DiseaseFORMA Therapeutics Announces FT-4202 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Sickle Cell Disease
www.businesswire.com - February 20 at 10:58 AM
Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2020 AstraZeneca PlcGlobal Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market 2020 AstraZeneca Plc
www.marketwatch.com - February 12 at 1:14 PM
Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market - Uncertainty PrevailsVaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market - Uncertainty Prevails
www.marketwatch.com - February 6 at 8:59 AM
Global Non-invasive Monitoring Devices Market Anticipated to Mask at a CAGR 5.6% by 2027|Omron Corporation, Vaso CorporationGlobal Non-invasive Monitoring Devices Market Anticipated to Mask at a CAGR 5.6% by 2027|Omron Corporation, Vaso Corporation
www.marketwatch.com - January 24 at 9:57 AM
Taqueria Company and Gonzz Steak Burger bring more choices to Evansville mallTaqueria Company and Gonz'z Steak Burger bring more choices to Evansville mall
www.msn.com - January 18 at 5:49 PM
How Visine Eye Drops In The Mouth Can Kill, Here Are Two CasesHow Visine Eye Drops In The Mouth Can Kill, Here Are Two Cases
www.forbes.com - January 18 at 5:49 PM
Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market With Moderate CAGR in Forecast Period 2019 to 2026Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market With Moderate CAGR in Forecast Period 2019 to 2026
www.marketwatch.com - January 9 at 6:35 AM
Global Blood: Beware Of This Key Investment Risk As Voxelotor Enters CommercializationGlobal Blood: Beware Of This Key Investment Risk As Voxelotor Enters Commercialization
seekingalpha.com - December 2 at 6:22 PM
CRISPR Therapeutics: Progress In Treatment Of Blood Disorders Using CRISPR/Cas9 Looks Highly PromisingCRISPR Therapeutics: Progress In Treatment Of Blood Disorders Using CRISPR/Cas9 Looks Highly Promising
seekingalpha.com - December 2 at 1:21 PM
Vertex, CRISPRs Gene Editing Drug Shows Positive Early DataVertex, CRISPR's Gene Editing Drug Shows Positive Early Data
finance.yahoo.com - November 20 at 1:00 PM
New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell diseaseNew Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
markets.businessinsider.com - November 15 at 7:12 PM
FDA approves first targeted therapy to treat patients with painful complication of sickle cell diseaseFDA approves first targeted therapy to treat patients with painful complication of sickle cell disease
finance.yahoo.com - November 15 at 7:12 PM
Vaso Corporation Reports Financial Results for Third Quarter 2019Vaso Corporation Reports Financial Results for Third Quarter 2019
finance.yahoo.com - November 14 at 1:07 PM
Why Banda Los Sebastianes New No. 1 Song Will Keep Them Striving for MoreWhy Banda Los Sebastianes' New No. 1 Song Will Keep Them 'Striving for More'
www.msn.com - November 8 at 10:35 PM
Vaso-Occlusive Crisis Pipeline Insight Report 2019 - ResearchAndMarkets.comVaso-Occlusive Crisis Pipeline Insight Report 2019 - ResearchAndMarkets.com
www.businesswire.com - October 23 at 12:55 PM
Vaso Actives Claims Prompt SEC to Step InVaso Active's Claims Prompt SEC to Step In
www.thestreet.com - October 13 at 12:57 AM
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.